Drupal.behaviors.print = function(context) {window.print();window.close();}>
Soft Biopharma Sales Contribute to 10 Percent Drop in SDIX Q2 Revenues
August 08, 2012
Soft Biopharma Sales Contribute to 10 Percent Drop in SDIX Q2 Revenues
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
SDIX's Q1 Revenues Slide 15 Percent
May 10, 2012 / GenomeWeb Daily News
SDIX's Q2 Revenues Rise 4 Percent
July 28, 2011 / GenomeWeb Daily News
SDIX Posts 12 Percent Q1 Revenue Growth
May 13, 2011 / GenomeWeb Daily News
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
Cancer Genetics Reports 45 Percent Increase in Q1 Revenues, Maps out Growth Strategy
May 16, 2013 / GenomeWeb Daily News